Search - tctmd.com

Displaying 781 - 800 of 1322

Sort: Relevancy | Date

News Industry News

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

November 02, 2015

News Features

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

Yael L. Maxwell

November 01, 2015

News Daily News

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Todd Neale

October 26, 2015

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

Presentation TCT 2015

Incorporating Quality-of-Life and Patient-Oriented Outcomes in the Device Regulatory Approval Process

Presenter: Andrew Farb, Gregg W. Stone, John A. Spertus

October 14, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Conference News TCT 2015

FDA Speaker Outlines a Novel Vision for Device Regulation

October 13, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

Todd Neale

October 12, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

Presentation TCT 2015

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Presenter: J. A. Mustapha, Craig M. Walker, Gary M. Ansel

October 11, 2015

News Opinion Fellow Talk

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

October 11, 2015

News Industry News

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

October 11, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

News Industry News

SentreHEART Receives CE Mark Approval for the LARIAT Surgical Left Atrial Appendage Suture Delivery Device

October 08, 2015

News Daily News

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

L.A. McKeown

October 08, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

Advertisement

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

My Takeaways From TCT 2015

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Incorporating Quality-of-Life and Patient-Oriented Outcomes in the Device Regulatory Approval Process

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

FDA Speaker Outlines a Novel Vision for Device Regulation

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Robotic Systems to Play Greater Role in Cath Lab of the Future

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

What the Device Approval Trials Will Tell Us About the Endovascular Approach to CLI and What They Wont

Researcher Much? A Brief Review of TCT’s Clinical Trial Design and Interpretation Sessions

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

Use of LAA Occlusion in Low-Risk Patients Debated

SentreHEART Receives CE Mark Approval for the LARIAT Surgical Left Atrial Appendage Suture Delivery Device

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

Boston Scientific Announces Scheduled Presentations At TCT 2015

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content